DR. MARTENS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85 GBX | +2.60% |
|
+8.42% | -4.06% |
| 05-13 | BAE Systems and Mondi cut to 'neutral' | AN |
| 04-29 | Deutsche Bank Initiates Dr. Martens at Hold | MT |
Presenter SpeechKenneth Wilson (Executives)Good afternoon, everyone, and welcome to Camden, an...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company operates through three reporting segments: Europe, the Middle East and Africa (EMEA); Americas; and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels, and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion, and Casual collections. It offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. It operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.
Sector
Footwear
Calendar
2024-05-30
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
0.8285
GBP
Average target price
0.7302
GBP
Spread / Average Target
-11.86%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -4.06% | 1.01B | |
| +32.93% | 22.73B | |
| +32.39% | 11.43B | |
| +9.75% | 10.41B | |
| -3.14% | 8.66B | |
| +1.78% | 8.43B | |
| +21.68% | 3.57B | |
| +75.93% | 3.21B | |
| -7.88% | 2.48B | |
| -18.01% | 2.05B |
- Stock Market
- Equities
- DOCS Stock
- News Dr. Martens plc
- Transcript : Dr. Martens plc - Special Call
